SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " tide " 407 found 🔀 AI-powered Shuffle
The copper peptide trend has gone from creams to injections
Copper peptides are one of the biggest viral trends on social media. People are smearing the electric blue tincture on their face, and even injecting it under the skin. The compound is supposed to deliver flawless and firm skin, promote wound healing and other anti-aging effects. So what's the evidence behind GHK-Cu? NPR's Will Stone reports.
Alabama Fans Should Be Worried About This
Alabama couldn’t have asked for a much better start to the season. The Crimson Tide destroyed East Carolina 48-10 , Keelon Russell looked impressive in his first career start and Alabama finished with nearly 500 yards of offense. But there was one problem that looked very familiar. Ryan Coleman-Williams is still dropping passes. Coleman-Williams struggled…
Growth hormone peptides promise to stall aging—but does the science stack up?
Sermorelin, tesamorelin and other growth hormone peptides are being touted as antiaging elixirs, but what evidence is behind those claims?
Insight: Booming weight-loss drug demand in Brazil fuels thriving black market and health fears
When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the active ingredient in the popular weight-loss drug Mounjaro, mixed inside the sweet spread.
Booming Weight-Loss Drug Demand in Brazil Fuels Thriving Black Market and Health Fears
By Luciana Magalhaes SAO PAULO, Aug 31 (Reuters) - When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the active ingredient in the popular weight-loss drug Mounjaro, mixed inside the ...
Tidelands Health offers hands-on nursing event for high school students
Tidelands Health is offering its annual “Nurses are Extraordinary” event to selected high school juniors and seniors in Georgetown, Horry and Williamsburg counties.
24th Annual BioBlitz at Seacoast Science Center
Join Seacoast Science Center on Sunday, September 20, 2026 for the 24th BioBlitz, the non-profits annual community science event in Odiorne Point State Park. Families and nature enthusiasts team up with SSC naturalists and guest experts to explore the Park’s habitats to find and identify as many different species as possible in just one day! BioBlitz is a great way to get kids (and adults!) excited about science, learn about the park’s biodiversity, and discover how you can help protect our natural world.Like an extreme nature scavenger hunt, BioBlitz offers many opportunities for all ages to gain knowledge and hone skills in their favorite areas of nature! Habitat, plant, and animal explorations are scheduled throughout the day, allowing participants to choose among activities that interest them the most. With seven distinct natural habitats to survey, there’s something for everyone! Explorations include tide pools, mammals, seine netting, salt marsh, mushrooms, and more (see full schedule online, subject to change). Find all the details on the BioBlitz web page, and get your tickets to explore with SSC: https://www.seacoastsciencecenter.org/events-overview/bioblitz
FDA approves tirzepatide for reducing cardiovascular risk in adults with type 2 diabetes
The popular drug, sold by Eli Lilly and Company under the brand name Mounjaro, has been at the center of many cardiology trials over the years. It is now the first dual GIP and GLP-1 hormone receptor agonist approved by the FDA for this indication.
Alabama defensive lineman to reportedly miss 2026 season with injury
The defensive lineman was entering his third season at Alabama, and will reportedly miss the 2026 season due to an injury.
Medical providers say public excitement over peptides is outpacing the science
Med-spas, weight loss clinics and wellness centers around Charleston are advertising peptides, compounds marketed for muscle growth, skin health, sleep and energy.
Cowboys 330-Pound Punisher Looks Poised for Breakout 2026 Season
The 2025 NFL Draft class for the Dallas Cowboys is still developing, but it’s starting to look like a solid group.Dallas’ top pick, and the one everyone is focused on, is starting offensive guard Tyler Booker. Not many people had expectations for the Alabama Crimson Tide product, but Booker is turning into a solid player.Booker […] The post Cowboys 330-Pound Punisher Looks Poised for Breakout 2026 Season appeared first on HEAVY.
Santana: Hotel Workers Caught Up In Political Rip Tides At Dana Point Harbor
The race for a supervisors’ seat in South Orange County is having a real impact on a lucrative deal to redevelop hotels and boat slips.
Common medications may change your gut for years
Common medications may reshape the gut microbiome long after the last dose is taken. In a study of more than 2,500 people, researchers found lasting microbial changes linked not only to antibiotics, but also to antidepressants, beta-blockers, acid-reducing drugs, and benzodiazepines. Some effects were still detectable years later, suggesting past medication use may strongly influence the gut bacteria people carry today.
Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online
/PRNewswire/ -- Vector Science & Therapeutics Corp. (TSXV: PAIN) (the "Company") today announced that the first of four planned manufacturing suites at its...
Where ESPN ranks Alabama in preseason college football power rankings
Alabama is considered a Top 25 team entering the 2026 season. Where does ESPN rank the Tide in the preseason?
Endometriosis diagnosis linked to long-lasting mental health burden
Women who are later diagnosed with endometriosis have a markedly higher use of antidepressant and anxiety medication and are far more often in contact with psychiatric hospital departments than other ...
Alabama duo named to 2026 USA TODAY Sports preseason All-America team
The Alabama defensive backs have been named to USA TODAY Sports' 2026 preseason All-America college football team.
6 Ways PS5's Tides of Annihilation Blew Me Away After 2 Hours of Play
The tide is high-ly impressive
We Played Tides Of Annihilation For Two Hours And Came Away
Senior Associate Editor Wesley LeBlanc traveled to Chengdu, China, to go hands-on with Eclipse Glow's debut action game. - Game Informer
Smithsonian Brings Sandy Beach Scientists to Texas A&M Galveston
Scientists from the U.S. and South America are workshopping at Texas A&M University at Galveston (TAMUG) this week to expand sandy beach research and broaden collegiate learning opportunities.The Tides of Opportunity Project, co-led by the Smithsonian’s Marine Global Earth Observatory (MarineGEO) Program, TAMUG, the Smithsonian Marine Station, the Smithsonian National Zoo and Conservation Biology Institute, and the University of Miami, is a collaborative monitoring project with marine science professors and their students.Tuesday, Aug. 18, through Friday, Aug. 21, 15 professors and marine science professionals from the United States, Brazil, Peru, and Urugay will co-design a sandy beaches monitoring protocol and associated course modules and test the protocol in the field.The goal is to incorporate sandy beach monitoring protocols into marine science courses, which college faculty and students can use to achieve learning goals while providing essential data can help researchers diagnose the health of an understudied critical coastal habitat.Dr. Guilherme Corte, an assistant professor of marine biology in the College of Marine Sciences and Maritime Studies at TAMUG, is a principal investigator for MarineGEO. Texas A&M University at Galveston students and faculty package samples collected on the beach to take to campus for study in the Benthic Ecology Lab. Credit: TAMUG Division of Marketing and Communications“One third of the world’s ice-free coastlines are made of sandy beaches, and they go from pole to pole,” Corte said.However, despite their abundance and place as one of the most accessible coastal ecosystems for college-level education and research, they remain critically understudied.The Tides of Opportunity Project recognized that accessibility makes sandy beaches uniquely suited for engaging professors and students, including those with limited resources.“Any students can do sandy beach research,” Corte said, encouraging instructors to help students take a break from typing questions into artificial intelligence tools and embrace opportunities to do real science. “Providing this hands-on experience is something unique.”Tides of Opportunity Project goals include:Training a cohort of professors from across the Americas in standardized sandy beach monitoring methods; Equipping participating faculty with classroom modules, field tools, and multilingual teaching materials; Expanding MarineGEO with new monitoring sites focused on the implementation of long-term sandy beach monitoring; Strengthening hands-on, college-level learning experiences; And cultivating interest, learning, and efficacy in science among college-level students.By the end of this week, workshop participants plan to have a final version of the protocol and associated course modules that we can share with professors shortly after the workshop ends to then test with their students in courses that take place between September 2026 and February 2027.The scheduleDay 1: Tuesday, Aug. 18Location: Aggie Special Events Center (ASEC), Rooms 102 B and C, Texas A&M University at Galveston 8:30 – 9 a.m. Breakfast9 – 9:30 am Welcome and brief group introductions9:30 – 10 a.m. Introduction to Tides of Opportunity Project, Design Workshop, MarineGEO, and the Connecting Coastlines to Campuses Program (presentation)10 a.m. – 1 p.m. Introduction to workshop participants and project coordination team (presentations by each participant)• Brief lunch break from 12-12:30 p.m.1 – 3 p.m. Discussion about why collaborative science matters (presentation and interactive group discussion)3 – 4:15 p.m. Introduction to sandy beaches (presentation and group discussion)Day 2: Wednesday, Aug.19Location:• Morning sessions: ASEC Rooms 102 B and C, Texas A&M University at Galveston • Afternoon sessions: Corte’s field site (location available upon request)8:30 – 9 a.m. Breakfast9 a.m. – noon Prep for fieldwork (presentation and interactive group discussion)• Finish conversation about importance of studying sandy beaches• Go through sandy beaches monitoring protocol and field sheetsNoon – 12:45 p.m. Lunch12:45 – 1:30 p.m Prep for field (including driving to the field site)1:30 – 5:30 p.m. Fieldwork & bring samples back to TAMUGDay 3: Thursday, Aug. 20Location:• Breakfast: ASEC Rooms 102 B and C, Texas A&M University at Galveston • Fieldwork: Guilherme’s field site (location available upon request)• Lab/afternoon sessions: TAMUG lab (location available upon request) and ASEC Rooms 102 B and C8:30 – 9 a.m . Breakfast9 – 11 a.m. Return to field• Shorter field trip – recovering samples left out overnight11 a.m. – noon Lab work12 – 12:45 p.m. Lunch12:45 – 2:45 p.m. Continue lab work3 – 5 p.m. Discuss with professors the feasibility of implementing protocol in their courses and where might need to make changes (discussion)Day 4: Friday, Aug. 21Location: ASEC Rooms 102 B and C, Texas A&M University at Galveston 8:30 – 9 a.m. Breakfast9 a.m. – noon Group Discussion• How to evaluate student learning and engagement• Course modules• Next steps
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling
The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.
RFK Jr.’s dangerous love affair with peptides
The health secretary takes a 19th-century approach to U.S. drug safety standards.
Scientists Are Building a 'Noah’s Ark' of California’s Tide Pools
It will help better track the effects of climate change on the ecosystem.
Peptides talk is everywhere: But what does the science say?
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
Should Seahawks Sign Controversial Lions First-Round Pick Terrion Arnold?
Seattle scouts a potential defensive cornerstone as the former Crimson Tide standout seeks a fresh start following his release from Detroit, adding intrigue to an evolving secondary.
Alabama Position Preview: The Future vs The Veteran at Quarterback
Five-star phenom Keelon Russell battles seasoned veteran Austin Mack as Kalen DeBoer weighs explosive potential against established trust to lead the Crimson Tide's post-Simpson era.
Kylo Peptides Expands Research Catalog to 36 Compounds as Peptide Science Enters a Record Growth Cycle
US research-peptide supplier scales its catalog against a market that analysts value between $47 billion and $141 billion, as peptides hold near 10% of new FDA drug approvals and GLP-1 use among American adults doubles in 18 months.Sheridan, Wyoming, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides, a US supplier of research-grade peptides, has expanded its catalog to around 36 peptides and research blends, the company announced today. The milestone lands during the most active growth period in t
Unregulated use of peptides raises alarm among researchers
Driven by social media hype and a growing distrust of public health guidance, consumer demand for experimental peptides has exploded over the last decade.
Trans federal employees sue over revoked health coverage
Expanded retatrutide access, the cost of the 2025 measles outbreak, and more health news from Morning Rounds
Alabama Crimson Tide WR is Already on Transfer Watch
This Alabama Crimson Tide wide receiver could be facing a do or die season in 2026.
Alabama Was Called Cheap; Now Its Strategy Looks Smart
While rivals chase high-priced transfers, the Crimson Tide prioritizes roster continuity. This calculated shift toward internal stability over flashy recruiting hauls marks a new era for sustaining dominance.
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next
Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging. And six of these compounds cleared a major hurdle last week, when an advisory panel to the US Food and Drug Administration voted in favor of making them available through compounding pharmacies.
In the unbridled online marketplace for peptides, one vendor is sentenced to nearly 6 years in prison
The Real Antidepressant Crisis
Robert F. Kennedy Jr. says Americans overuse SSRIs. In fact, too many people who need depression treatment aren’t getting any.
The new "science golden age" looks suspiciously like a grift
This edition of PN is made possible by paid subscribers. Become one ⬇️ 🚀 Subscribe to PN 🚀 The Trump regime is trying to usher in a “Golden Age in Science” where scientific research is run like a Trump family business, artificial intelligence is all that matters, profit is everything, and expertise is for chumps. Or at least that’s the vision emerging from a new 123-page “Report to the President” from Michael Kratsios, the Director of the White House Office of Science and Technology Policy. In a normal administration, you could probably skip over learning about a science policy document — but this is no normal administration, and this is no normal science policy document. Instead, it’s Trump’s attempt to end the actual golden age of science that was kicked off in 1945 with the publication of '“The Endless Frontier” by Vannevar Bush. [ ](https://www.publicnotice.co/p/harmeet-dhillon-portland) [ Harmeet Dhillon demonstrates danger of posting through it ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Liz Dye · Jul 29 [ Read full story ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Bush, at President Franklin Delano Roosevelt’s request, laid out a vision of federal support for science that centered on funding universities to do basic research, saying that as long as those institutions were “vigorous and healthy and their scientists are free to pursue the truth wherever it may lead, there will be a flow of new scientific knowledge to those who can apply it to practical problems in Government, in industry, or elsewhere.” Kratsios’s report is supposed to be the successor to Bush’s, and even apes the format, but this isn’t really a document about science policy. It’s one about ending science research as we know it in favor of shoveling cash at big tech companies. While it might be temping to wave this away as an aspirational policy document, Trump has already begun to shift billions in research funds to AI projects and has taken a hatchet to science funding across the board. He’s teed up the shift Kratsios proposes here, and since neither Congress nor the Supreme Court seem inclined to stop him from doing whatever he wants with taxpayer money, it isn’t doomering or hyperbole to say we are staring down the barrel of a world where the only “science” the government intends to support is for-profit tech and defense advancements. Science for dummies Part of how you can tell this isn’t a document about science is that you are immediately faced with an absolute wall of business-speak of the worst sort. Did you know we must “tightly couple our science and technology enterprises to ensure that groundbreaking ideas invented in the United States are rapidly prototyped, tested, manufactured, and scaled domestically”? You do now! That tone isn’t surprising, because Kratsios has no background in science or research. He has a bachelor’s in political science and spent most of his career working for Peter Thiel at Thiel Capital. After a stint in the first Trump administration as Chief Technology Officer, where he also did not do any science, Kratsios was tasked in 2020 with overseeing the Pentagon’s research budget for a brief time, a position that, as the Wall Street Journal put it, “carries a great deal of power in terms of dictating investment allocations.” He spent the Biden years at Scale AI as “head of strategy,” which you will also note is neither a science nor a research job. But Scale AI has contracts with the Department of Defense and, as the Washington Post wrote in 2023, “has been aggressively pitching itself as the company that will help the US military in its existential battle with China.” And now you have the necessary background for our new golden age, which is going to be a golden age of taking money away from scientists and universities and giving it to companies like Scale AI. A note from Aaron: Working with brilliant contributors like Lisa takes resources. If you aren’t already a paid subscriber, please become one to support our work. 👇 Subscribe In a genuinely galling move, Katsios spends a lot of time slamming universities because of “administrative burdens on researchers” and the “well-documented inefficiencies” in academia, the message being that those damn universities waste the time of amazing researchers with paperwork. Except it’s the administration that is attempting to impose inefficient, unnecessary burdens on those researchers with a proposed Office of Management and Budget rule that would require senior political appointees to approve every science grant and ensure it aligns with Trump’s personal priorities. Researchers would also have to seek prior government approval to attend conferences or publicize their research. And political appointees could terminate any grant at any time if they feel like it. [ ](https://www.publicnotice.co/p/omb-rule-science-funding) [ The murder of expertise ](https://www.publicnotice.co/p/omb-rule-science-funding) Lisa Needham · Jun 11 [ Read full story ](https://www.publicnotice.co/p/omb-rule-science-funding) But when it comes to AI, we’re going to “restore permissionless innovation.” The report proposes to give lucky ducky innovators a pile of cash up front for grants lasting five years or longer, saying “awards should be fully-funded in year one, with all resources earmarked upfront, to minimize administrative burdens and reduce pressure for researchers to generate intermediate results to secure continued funding.” Yeah, wouldn’t want to have to make the Very Special Tech Bros show results or get money parceled out year by year like the plebes at universities. The report also proposes that we should have “fast grants” with “simplified applications requiring just a few pages of writing” because that is definitely how science works, just writing a bit off the dome and getting some cash. [ ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) [ Tech elites are turning AI into ChatGPTrump ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Paul Waldman · July 29, 2025 [ Read full story ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Oh, and we should have prizes and challenges, where multiple teams compete. The proposed prizes include incentives like “advance procurement commitments,” which means the federal government agrees to buy whatever is being developed. There’s also “regulatory fast-tracking,” making sure all those great AI thingies don’t have to wait too long to be unleashed on a market. These aren’t incentives to do science. These are incentives to develop things with tax dollars that you can then sell to the government for more tax dollars. In the suggestion that might be the most unhinged, the most very opposite of how both government and research work, our new age will include “golden tickets.” That’s where an individual reviewer in an agency — yes, just one person — can “recommend unconventional proposals that may not pass consensus-driven review panels” because somehow this will “surface valuable ideas too divisive for committees and attract higher quality reviewers by empowering them to exercise independent scientific judgment.” Yes, that’s saying that a random person in an agency should be able to shovel money at some idea even if it can’t pass a review panel, and that the opportunity to do so will attract better employees because apparently all the best minds in science are chomping at the bit to be allowed to unilaterally fund AI research based on their personal vibes. But that isn’t at all how actual science works, and actual scientists aren’t unhappy about review panels. They work collaboratively, not siloed in some secret race to create the next AI chatbot. A 2020 study by the National Bureau of Economic Research examined whether peer review panels succeed in helping agencies predict which research ideas will best advance science. Peer review was better at finding “diamond in the rough” applicants than a single government program official. How about that. Trump always wants a taste It’s painfully clear that what Katsios is trying to do here is turn the whole of government science research and funding into the sort of “move fast and break things” paradigm that is the hallmark of big tech. That method works to line the pockets of tech executives, but it isn’t science. There’s a reason the government funds different kinds of research than private tech companies do. What Katsios either fails to understand or deliberately ignores is that the federal government is the main funder of basic research precisely because it can take a long time for it to bear fruit and is not intended to be profitable as such. “Basic” here does not mean rudimentary or simple, but rather research that is designed to advance scientific knowledge instead of achieving a specific outcome or product. Big tech companies don’t widely fund that sort of research, because it doesn’t make them money. Industry dollars account for only about 20 percent of basic research funding, while the government contributes around 60 percent. Big tech companies and startups do, however, rely on and benefit from that basic research. A 2019 study found that 35 percent of all patents obtained by venture-backed startups from 1976 to 2016 cited federally supported research. Basic research funded by the NIH contributed to every single drug the FDA approved from 2010 to 2016. [ ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) [ The Saudi nuclear farce and governance by whim and meme ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Noah Berlatsky · Jul 27 [ Read full story ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Unlike inventing the next ChatGPT, actual science is slow and iterative. Government funding of research that, on its face, would not appear to lead to any big new invention is actually what underpins those big new inventions. If the government hadn’t funded research into desert lizard venom, we wouldn’t know about semaglutide, and we wouldn’t have Ozempic. If research scientists hadn’t studied how bees optimize nectar foraging within a colony, we wouldn’t have the algorithm that assigns internet traffic across computer servers. The report assiduously ignores that a symbiotic, profitable relationship between the federal government, universities, and private companies already exists. Each federal research dollar generates about $1.50 to $3.00 in long-term economic benefits. The $36 billion the government awarded in NIH research funding in fiscal year 2025 generated $94 billion in new economic activity. Trump’s proposed new golden age is intended to strip those billions from universities, resulting in the dismantling of departments and the shuttering of labs. But Katsios has a plan for that: Universities should just become trade schools to churn out no-show STEM degrees! “Require universities and community colleges to embed practical technical training and externships into STEM curricula. Let hands-on experience and industry credentials count toward degrees.” It’s quite the feat to, on the one hand, strip schools of funding for scientific research while simultaneously demanding to control what is taught and, oh, also, colleges need to give degrees to employees at big tech companies just for being employees at big tech companies. The new golden age would also exacerbate the brain drain Trump’s policies have already caused. Nature found that in the first quarter of 2025, US scientists submitted 32 percent more job applications abroad than in 2024. A March 2025 poll by Nature of roughly 1,600 scientists found that over 1,200 said they were considering leaving the country. Europe is investing $565 million to make it a “magnet for researchers” and provide funding for scientists who relocate. The new golden age is also about embedding Trump’s xenophobia into the fabric of American science. The report complains of an “over-reliance on foreign students” that “creates a security challenge our institutions are ill-equipped to address” and that a “reliance on foreign talent sidelines American students.” This is, to put it mildly, nonsense. International students pay far higher tuition and often receive no financial aid. Their tuition dollars are what make it possible for American students to get financial aid. In the 2023-2024 school year alone, international students contributed $43.8 billion to the US economy and supported over 378,000 jobs. Those 1.1 million international students accounted for only six percent of the total number of students in higher education that year, but were such an economic engine that for every three international students, one job was created or supported. It’s impossible not to wonder whether part of Trump’s loathing for universities and their leading role in scientific research is that there is no way for him to corrupt the process and make money off it in the same way he can by giving millions and billions to Silicon Valley types who, in turn, give him millions in cash. There’s no way for his children to invest in universities that the government then gives no-bid contracts to, fattening the family’s bottom line, which is pretty much the Trump sons’ current venture capital practice. Trump and Katsios’s view of science is narrow, cramped, and wrong. We’re not in a crisis, we’re not a failed state. We’ve been a science superpower for decades, and the only thing that threatens that is Donald Trump. Tech bros are already living high off the hog in this administration. They don’t need any more of our tax dollars. Hopefully this new golden age never comes to pass. Thanks for reading Public Notice. This post is public so feel free to share it. Share We’ll be back with more tomorrow. If you appreciate today’s PN, please do your part to keep us free by signing up for a paid subscription. 🚀 Subscribe to PN 🚀 Thanks for reading, and for your support.
Florida urges doctors not to prescribe mental health medication for children
Florida's surgeon general has warned doctors not to prescribe antidepressants and other psych drugs for children, instead urging comprehensive evaluations and behavioral therapy as first line treatment options.
Jumbo Package: Athlon pegs Alabama football 7th in the SEC
Your latest Crimson Tide news and notes.
Compounded Semaglutide vs. Wegovy For Weight Loss: What You Need To Know
Compounded Semaglutide vs. Wegovy For Weight Loss: What You Need To Know
Alabama's Kalen DeBoer Sets the Record Straight After Recent Backlash
Alabama Crimson Tide coach Kalen DeBoer has set the record straight on some comments he made that resulted in fan backlash.
Liraglutide For Weight Loss: How It Works, Safety Considerations & More
Liraglutide For Weight Loss: How It Works, Safety Considerations & More
Peptides are the latest wellness trend – but do they work?
A drug advisory committee in the US has recommended approval for several experimental peptides. But there have been no large-scale tests of these new compounds in humans, finds columnist Grace Wade
Alabama adds commitment from top 2028 linebacker prospect
The Crimson Tide received a commitment from a premier pass rusher.
Jumbo Package: Alabama adds 4-star EDGE to 2028 class
Your latest Crimson Tide news and notes.
FDA takes up peptide therapies as hype outpaces science
A slate of popular peptide therapies has won the backing of a key advisory panel to the federal government – a step that could eventually open up broader
Former Alabama Crimson Tide Player Blasts Kalen DeBoer
A former Alabama Crimson Tide player has taken quite a shot at Kalen DeBoer.
Kalen DeBoer's Alabama Future Lands Resounding Take From Insider
Is it possible that the Alabama Crimson Tide could part ways with Kalen DeBoer after 2026?
Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Peptide boom has states scrambling to protect consumers, Post investigation finds
The Post surveyed states’ pharmacy, medical and nursing boards to reveal the gaping regulatory holes for medspas and peptides.
FDA panel votes to loosen restrictions for controversial peptides
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
US health panel recommends easing restrictions on controversial peptides
Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.
FDA reviews peptide injections favored by RFK Jr. and wellness influencers
Federal health advisers are meeting to review a group of controversial chemicals called peptides
Alabama endures major roster turnover from 2025
TUSCALOOSA, Ala. (WIAT) — Less than 50% of Alabama’s 2025 roster is back with the Tide this season. One group bucking that trend, however, is the defensive back room. “The more time we’ve spent together, we’ve been able to communicate more,” cornerback Zabien Brown said. “You don’t have to spend as much time, you know, […]
Why aren’t health insurers rushing to cover GLP-1 prescriptions for beneficial weight loss?
In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation.
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-aging.
Jumbo Package: Alabama next up at SEC Media Days
Your latest Crimson Tide news and notes.
Lab-grown mini brains may predict which Alzheimer’s treatments will work
Miniature brain models grown from patients’ cells revealed striking differences in how Alzheimer’s-related tissue responds to an antidepressant. The organoids and the particles they release could eventually guide more personalized treatments and provide new clues for diagnosing the disease.
Does the science of peptides live up to the hype?
Synthetic peptides are getting some serious hype, from fitness influencers on your FYP to people seeking new options for chronic conditions. And while the human body already makes peptides, like insulin and the hormone oxytocin, most of the viral synthetic peptides are not approved by the Food and Drug Administration. Scientists say that raises some big concerns about safety and efficacy. So ahead of this week’s FDA meeting to discuss seven commonly used peptides, we get into the science with health reporter Sarah Boden.Interested in more science behind health trends? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. It includes perks like bonus episodes, early access, archive access, curated playlists and sponsor-free listening. Learn more at plus.npr.org.
FDA’s Review Of Peptides Signals A Growing Public Health Challenge— Separating Science From Hype
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
Inside Ukraine's secret uncrewed weapons revolution
We were given rare access to Ukraine's military units already deploying the technology of the future to turn the tide against Russia.
3 storylines for Alabama football entering 2026 SEC media days
Alabama head coach Kalen DeBoer is likely to speak on a variety of topics at 2026 SEC media days, most notably the Crimson Tide's quarterback battle.
Collagen Peptides Support Bone Health for Female Runners
The study found that biomarkers associated with bone formation increased and inflammation decreased with collagen peptide supplements
Opinion: Atlanta Black businesses are under threat. Here’s how to save them.
Black entrepreneurs should be able to thrive in Atlanta, but the price of commercial rents is driving businesses out. The Staying Power Toolkit will help turn the tide.
Seven peptides are under review by an FDA panel this week. Here’s everything we know
The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.
OpenAI has seen a 'resurgence' of interest in secondary markets.
For most of this year, investors couldn't get enough of Anthropic while ignoring OpenAI. Now the tide is turning following the release of new models.
Israel’s $50 Million Experiment to Change U.S. Public Opinion
Israel deploys AI and payments to conservative media to try to beat back the tide of unfavorable U.S. views about its handling of wars in Gaza and Iran.
This Is The Alabama’s Biggest Question Entering 2026
Alabama enters the 2026 season with expectations as high as ever, but unlike many recent Crimson Tide teams, there is one glaring question that could determine whether Kalen DeBoer’s third season ends with a College Football Playoff run or another disappointing finish. Can Alabama finally establish a consistent running game? The numbers from last season…
Low-cal sweeteners can change gut bacteria — especially if you're on a popular antidepressant
That guilt-free treat may not be as innocent as it seems.
Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
Jennifer English Steps Away From Tides of Annihilation Role Due to Health Concerns
English actress Jennifer English is stepping away from her role as the protagonist in Eclipse Glow Games’ Tides of Annihilation due to health issues.
Health Brief: Trump’s Obamacare gamble hits court trouble
Plus: A federal advisory panel is facing scrutiny over members’ ties to peptide products
Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart
When patients take semaglutide, the dose appears to offer more cardiovascular benefits than weight loss.
FDA raised conflict of interest concerns ahead of new peptide panel
That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides previously restricted over potential safety concerns.
A Tide-Fueled Trove of Biodiversity in Guinea-Bissau
The expansive mudflats, sandy beaches, and mangrove forests of the Bijagós archipelago support an array of migratory shorebirds and large numbers of sea turtles.
Scientists tested 39 sweeteners and found unexpected gut effects
A large laboratory study found that many commonly used sweeteners can directly change the growth of gut bacteria. Researchers identified more than 100 cases in which sweeteners behaved differently when combined with medications, caffeine, or flavorings. The combination of isosteviol and the antidepressant duloxetine was especially disruptive, reducing beneficial bacteria and overall microbial diversity.
Politics: What Changing Political Tides Mean For Gaza
Israel is expanding its command of Gaza and now controls almost 70 percent of the tiny enclave that’s home to more than two million people.More than 1,100 Palestinians have been killed since the ceasefire between Israel and Hamas nearly a year ago. Some 73,000 Palestinians have been killed in total since Israel’s military offensive began after Hamas fighters killed 1,200 people on Oct. 7, 2023. Meanwhile, dozens of aid groups have been barred from operating in Gaza.Almost every Gazan is dealing with hunger, with 77 percent of the population facing high levels of food insecurity, according to the World Food Programme.So, what do these shifting lines of control mean for those in need? And how could changing political tides affect the situation?Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
FDA approves first cholesterol pill of its kind
Enlicitide, the new oral PCSK9 inhibitor from Merck, will be sold under the brand name Lipfendra. It is approved to reduce LDL-C in patients with hypercholesterolemia, including HeFH.
What changing political tides mean for Gaza
More than 1,100 Palestinians have been killed since the ceasefire between Israel and Hamas nearly a year ago.
Killings of three British politicians in a decade shine light on febrile political mood
For the third time in a little over a decade, British lawmakers stood up one-by-one in Parliament on Monday, paid tribute to a slain politician, and echoed each other’s fears about the rising tide of violence in politics.
Semaglutide dose may matter more than weight loss for heart health
The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging existing treatment assumptions.
HHS presses ahead with effort to curb antidepressant use
In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.
Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides
Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved populations and combat rare diseases.
UK becoming ‘wild west’ for experimental peptides, expert warns
Prof Channa Jayasena says growing online sales of unregulated drugs risk fatalities as responsibility falls between regulators
Columbia scientists discover surprising link between serotonin and heart valve disease
Scientists have uncovered evidence that serotonin, the chemical best known for regulating mood, may also speed the progression of a common heart valve disease in some people. The research suggests that patients with degenerative mitral regurgitation who take SSRI antidepressants and carry a specific genetic variant may develop severe valve damage sooner, potentially requiring surgery at a younger age.
Health Brief: The peptide showdown
Plus: The push to expand peptide access is running into resistance from FDA scientists
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers linking the increase to accidental dosing mistakes rather than intentional misuse. Simple education about proper weekly dosing and gradual dose increases could help prevent many of these avoidable incidents.
Students Connect NASA Science With Indigenous Knowledge to Study Coastal Erosion
For the Pleasant Point Passamaquoddy Reservation, or Sipayik, the ocean has always been a teacher. Situated in what is known as Downeast Maine, along the shores of Passamaquoddy Bay, generations of Indigenous people have lived along the coast, learning from the tides, the land, and their elders. But today, the shoreline is changing more rapidly. Coastal erosion is slowly taking land away. Land that already holds a history of loss.
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally.
Palworld developer confirms when the version 1.0 update will go live
We're just days away now from the highly-anticipated 1.0 launch of Palworld, and we finally have an idea of when the update is actually going to arrive.
Changing tides: How gravity warps our oceans - Futura-Sciences
Why gravity makes water uneven Water at any point in the ocean is pulled straight down, perpendicular to what physicists call an equipotential surface. Along this surface, the pull of gravity is identical everywhere. The specific equipotential surface that aligns with global sea level is known as the geoid. On...
CBS Sports Names Alabama the Greatest College Football Program of Three Different Decades, and It's Hard to Argue
Spanning the 1930s to the 2010s, the Crimson Tide outpaced every other powerhouse to claim historic dominance across three distinct eras of gridiron excellence and consistency.
These 10 Medications May Raise Your Risk of Heat-Related Illness
As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, such as GLP-1s, diuretics, antidepressants, and beta-blockers. Here's what you need to know to stay safe.
Karpa Health Launches Turnkey Nationwide Telehealth Platform as GLP-1, Peptide, and Hormone Demand Accelerates
The all-in-one platform helps entrepreneurs, clinics, med spas, gyms, and wellness brands launch cash-pay telehealth programs nationwide. TAMPA, FL / ACCESS Newswire / July 3, 2026 / Karpa Health today announced the general availability of its turnkey ...
New HHS agenda targeting antidepressants creates pushback
As the Department of Health and Human Services creates new efforts to limit the overprescription of SSRI drugs, psychiatrists are pushing back.
Alabama target, top cornerback reportedly makes commitment decision
Top cornerback prospect Hayden Stepp has reportedly announced a commitment between Alabama, California, and Oregon.
Citadel Says Credit Unions Can Compete for Bigger Business Relationships
Small business banking has entered a period of reassessment as business owners look beyond rates and fees toward financial partners that can combine
Can GLP-1 medications improve health in people with Type 2 diabetes and PAD?
Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and hospitalizations among people...